Condition: Glaucoma and Ocular Hypertension · Sponsor: University of Pittsburgh
The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.
This description comes directly from the study's public registry record.
Tony Realini, MD, MPH · 3045986926 · hypotonywvu@gmail.com
Always discuss trial participation with your own doctor first.
| Harvard Eye Associates | Laguna Hills, California, United States | Recruiting |
| Doheny Eye Center UCLA | Pasadena, California, United States | Recruiting |
| University of California, Davis | Sacramento, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Mile High Eye Institute | Sheridan, Colorado, United States | Recruiting |
| Clear Vue Laser Eye Center | Lakeworth, Florida, United States | Recruiting |
| Northwestern Medical Group | Chicago, Illinois, United States | Recruiting |
| Chicago Arbor Eye Institute | Orland Park, Illinois, United States | Recruiting |
| Illinois Eye Center | Peoria, Illinois, United States | Recruiting |
| Wilmer Eye Institute Johns Hopkins | Baltimore, Maryland, United States | Recruiting |
| Massachusetts Eye and Ear | Boston, Massachusetts, United States | Recruiting |
| Ophthalmic Consultants of Boston | Boston, Massachusetts, United States | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04967989